DC-HIL(+) CD14(+) HLA-DR(no/low) Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma

類似資料

• DC-HIL-expressing Myelomonocytic Cells Are Critical Promoters of Melanoma Growth
  著者:: Chung, Jin-Sung, 等
  出版事項: (2014)
• The DC-HIL/Syndecan-4 Pathway Regulates Autoimmune Responses Through Myeloid-derived Suppressor Cells
  著者:: Chung, Jin-Sung, 等
  出版事項: (2014)
• DC-HIL/Gpnmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells
  著者:: Tomihari, Mizuki, 等
  出版事項: (2010)
• The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease
  著者:: Chung, Jin-Sung, 等
  出版事項: (2013)
• DC-HIL is a negative regulator of T lymphocyte activation
  著者:: Chung, Jin-Sung, 等
  出版事項: (2007)